United States · FDA National Drug Code directory
Lidocaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-0972_c792864a-cc36-431f-81d8-a849a3e3d16d
- Product NDC
- 0121-0972
- Form
- SOLUTION
- Composition / generic term
- Lidocaine Hydrochloride
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230731
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (0121-0972-51) / 50 mL in 1 BOTTLE, GLASS · 0121-0972-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →